BioSig Technologies, Inc.
BioSig Technologies, Inc. (BSGM) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for BioSig Technologies, Inc. (BSGM), featuring income statements, balance sheets, and cash flow data.
BioSig Technologies, Inc. (BSGM) Income Statement & Financial Overview
View the income breakdown for BioSig Technologies, Inc. BSGM across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $13000.00 | $0.00 | $13000.00 |
| Cost of Revenue | $0.00 | $167000.00 | $0.00 | $49000.00 |
| Gross Profit | $0.00 | -$154000.00 | $0.00 | -$36000.00 |
| Gross Profit Ratio | $0.00 | -$11.85 | $0.00 | -$2.77 |
| R&D Expenses | $6000.00 | $96000.00 | $156000.00 | $342000.00 |
| SG&A Expenses | $2.96M | $1.07M | $2.76M | $4.91M |
| Operating Expenses | $2.98M | $1.20M | $2.95M | $5.30M |
| Total Costs & Expenses | $2.98M | $1.20M | $2.95M | $5.30M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $5000.00 |
| Depreciation & Amortization | $21000.00 | $30000.00 | $31000.00 | $49000.00 |
| EBITDA | -$2.78M | -$1.22M | -$2.92M | -$3.86M |
| EBITDA Ratio | $0.00 | -$93.54 | $0.00 | -$296.69 |
| Operating Income | -$2.98M | -$1.18M | -$2.95M | -$5.29M |
| Operating Income Ratio | $0.00 | -$91.00 | $0.00 | -$407.08 |
| Other Income/Expenses (Net) | $184000.00 | $84000.00 | $1.04M | $1.38M |
| Income Before Tax | -$2.80M | -$1.10M | -$1.91M | -$3.91M |
| Income Before Tax Ratio | $0.00 | -$84.54 | $0.00 | -$300.85 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.81M | -$1.10M | -$1.91M | -$3.92M |
| Net Income Ratio | $0.00 | -$84.54 | $0.00 | -$301.38 |
| EPS | -$0.02 | -$0.008 | -$0.01 | -$0.03 |
| Diluted EPS | -$0.02 | -$0.008 | -$0.01 | -$0.03 |
| Weighted Avg Shares Outstanding | $140.42M | $140.42M | $159.84M | $129.16M |
| Weighted Avg Shares Outstanding (Diluted) | $140.42M | $140.42M | $162.009M | $129.16M |
Over the past four quarters, BioSig Technologies, Inc. demonstrated steady revenue growth, increasing from $13000.00 in Q2 2024 to $0.00 in Q1 2025. Operating income reached -$2.98M in Q1 2025, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$2.78M, reflecting operational efficiency. Net income dropped to -$2.81M, with EPS at -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan